PRAX as of Nov 3 · 08:23 ET
PRAXNasdaqPharmaceutical Preparations

Praxis Precision Medicines, Inc. · Brief

Next report

1 day

Nov 4 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 7≥ implied
avg implied
±17.0%
avg realized
±10.5%
Nov 6 '24—▼−1.18%—
Feb 28 '25±39.6%▼−40.64%×1.03
May 2 '25±12.4%▲+5.73%×0.46
Aug 4 '25±30.4%▼−5.55%×0.18
Q3 FY25±12.1%▼−4.14%×0.34
Feb 19 '26±7.3%▲+0.81%×0.11
Q1 FY26±7.4%▼−0.98%×0.13
Q2 FY26±9.4%▲+15.95%×1.69
quarterimplied−45%0+45%realized×
Q2 FY26±9.4%▲+15.95%×1.69
Q1 FY26±7.4%▼−0.98%×0.13
Feb '26±7.3%▲+0.81%×0.11
Q3 FY25±12.1%▼−4.14%×0.34
Aug '25±30.4%▼−5.55%×0.18
May '25±12.4%▲+5.73%×0.46
2 older reports
Feb '25±39.6%▼−40.64%×1.03
Nov '24—▼−1.18%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

4disclosed supplier and customer ties in SEC filingsSEC filings
5tracked funds holding PRAXN-PORT · Aug 31 '26

Bear2 of 4

5 of 22largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26
1.29%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

PRAX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±18.1% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.